Side Effect Management | News

Radiation Dermatitis May Depend on Skin Bacteria in Breast Cancer

March 1st 2024

By Ashley Chan

The skin microbiomes of patients with breast cancer who received radiation therapy may affect whether they get radiation dermatitis, a study showed.

Patients Should ‘Have the Conversation’ About Cannabis With Care Teams

February 28th 2024

By Alex Biese

“The biggest thing that I hate to see happen is that those conversations don't even happen [around cannabis and cancer],” said Dr. Brooke Worster.

Hispanic/Latino Survivors May Be Higher Risk for Cardiometabolic Comorbidities

February 27th 2024

By Ashley Chan

Sociodemographic factors affect some survivors who may not have easy access to health care or healthy food, reducing their health-related quality of life.

How Death Doulas Support Entire Families

February 27th 2024

By Alex Biese

Michelle Anderson-Benjamin, who received a diagnosis of metastatic breast cancer in 2022, works as a death doula to provide end-of-life support to patients and their families.

Virtual Reality Can Ease Pre-Chemotherapy Anxiety

February 22nd 2024

By Darlene Dobkowski, MA

An oncology nurse discusses how virtual reality can be used to educate patients and decrease stress before treatment or while in palliative care.

Chemo Modifications Can Improve Quality of Life in Older Patients

February 20th 2024

By Brielle Benyon

Straying away from standard-of-care chemotherapy can improve quality of life without sacrificing outcomes in older patients with advanced cancer.

More Than One-Third of Cardio-Oncology Patients Experience Sleep Apnea

February 15th 2024

By Alex Biese

“Sleep apnea assessment must be a part of routine risk assessment for patients undergoing cancer therapeutics,” one researcher stated.

Physical Activity May Help Reduce Pain in Cancer Survivors

February 14th 2024

By Ashley Chan

Survivors who were more physically active may experience less pain than survivors who were not as physically active, research found.

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

February 12th 2024

By Alex Biese

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

Lower Dose of Nausea, Vomiting Drug Controls Chemo Symptoms

February 10th 2024

By Darlene Dobkowski, MA

A 2.5-mg dose of olanzapine provided similar control of nausea/vomiting as the standard 10-milligram dose in patients with solid tumors receiving chemotherapy.